Effects and mechanism of ensartinib (X-396) on the adhesion and metastasis of non-small cell lung cancer cells.
The current study aimed to investigate the inhibitory effect and mechanism of ensartinib on adhesion, invasion and migration of non-small cell lung cancer (NSCLC) cells, including H460 and A549. Cell adhesion test, scratch test and Transwell cell invasion test were used to detect cell adhesion, migration and invasion. RT-PCR was used to detect the expression of MMP-2 and MMP-9 in H460 and A549 cells. Western blot was used to detect the expression of MMP-2 and MMP-9 proteins, ERK signaling pathway related proteins and p-Akt. Our data showed that ensartinib inhibited adhesion, invasion and migration of H460 and A549 cells in a concentration-dependent manner (P < 0.05). Ensartinib decreased the expression of MMP-2 and MMP-9 in H460 and A549 cells (P < 0.01). It also downregulated the expression of MMP-2 and MMP-9 in H460 and A549 cells, and inhibited the expression of Ras, p-c-Raf, p-ERK 1/2 and p-Akt upstream in a concentration- and time-dependent manner. Ensartinib inhibits the adhesion, invasion and migration of NSCLC cells, and such effect is related to downregulation of MMP-2 and MMP-9 expression, inhibition of ERK signaling pathway and p-Akt expression.